Last deal

Amount

Convertible Note

Stage

08.03.2019

Date

3

all rounds

$8M

Total amount

date founded

Financing round

General

About Company
Provenance is a clinical-stage biotechnology company developing immunotherapeutics to treat cancer and other diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Convertible Note

IPO status

Private

Description

Based in Waltham, Massachusetts, Provenance Biopharmaceuticals is focused on developing novel therapeutics for cancer and other life-threatening diseases. Their engineered antibody technologies harness the body's immune system to recognize and fight disease, specifically targeting tumor cells and preventing their recurrence. By utilizing the power of the immune system, Provenance aims to provide healthcare providers with effective treatments to cure cancer patients and improve their quality of life.
Contacts
Similar Companies
1000
Checkmate Theraputics

Checkmate Theraputics

Checkmate Therapeutics is a preclinical biotechnology company that develops treatments for cancer and other incurable diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Seoul, South Korea

total rounds

2

total raised

$6.55M
PDS Biotechnology Corporation

PDS Biotechnology Corporation

PDS Biotechnology Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

North Brunswick Township, NJ, USA

total rounds

5

total raised

$57.04M
AltruBio

AltruBio

AltruBio is a biopharmaceutical company developing targeted antibody therapeutics for cancer and immune-related inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Los Altos, CA, USA

total rounds

5

total raised

$327.61M

Pure MHC

Pure MHC is a biotech company that develops new therapeutics to treat cancer and infectious diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Austin, TX, USA

Financials

Funding Rounds
3
3

Number of Funding Rounds

$8M

Money Raised

Their latest funding was raised on 08.03.2019. Their latest investor For Good Ventures. Their latest round Convertible Note

Date 
Funding Round 
Investors 
Money Raised 
Lead 
08.03.2019
1
28.08.2018
1
22.12.2011
$8M
Co-Investors
Investors
1
0

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
No
Convertible Note
For Good Ventures

For Good Ventures

For Good Ventures is a San Francisco-based investment firm that supports innovative, positive-impact businesses.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Finance

Location

San Francisco, CA, USA

count Of Investments

45

count Of Exists

2

People

Employee Profiles
2

Jason M. Walsh

Co-founder, Senior Vice President and CFO

Stephen Gillies

Stephen Gillies

Founder, President, & CEO

Activity

Recent News
0